Detalhe da pesquisa
1.
Efficacy and safety of tixagevimab-cilgavimab versus SARS-CoV-2 breakthrough infection in the hematological conditions.
Cancer
; 130(1): 41-50, 2024 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37658645
2.
Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy.
Cancer
; 130(8): 1270-1280, 2024 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38153814
3.
Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma: a multi-center real-life survey.
Ann Hematol
; 2024 Apr 17.
Artigo
Inglês
| MEDLINE | ID: mdl-38630129
4.
Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life study.
Ann Hematol
; 2024 Apr 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38609726
5.
Gaucher disease prevalence in 600 patients affected by monoclonal gammopathy of undetermined significance.
Eur J Haematol
; 111(6): 922-929, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37747757
6.
Multicentric Castleman Disease and Concurrent Hematological Disorders: The Occurrence of Plasmacytoma and the Hypotheses Arising from Literature Review.
Acta Haematol
; 146(4): 331-337, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37068478
7.
Acquired hemophilia A following COVID-19 vaccination - The importance of prompt diagnosis: A case report.
Transfus Apher Sci
; 62(2): 103577, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-36151008
8.
Relapse of immune-mediated thrombotic thrombocytopenic purpura following mRNA COVID-19 vaccination: a prospective cohort study.
Haematologica
; 107(11): 2661-2666, 2022 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35511612
9.
Occurrence of lymphoproliferative disorders during ruxolitinib treatment: May fedratinib be the turning point?
Hematol Oncol
; 42(2): e3259, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38402568
10.
VEXAS-like syndrome: a potential new entity?
Ann Hematol
; 101(5): 1125-1128, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35318504
11.
Renal extramedullary hematopoiesis as an epiphenomenon of bone marrow dysfunction in a patient with primary myelofibrosis: A rare case report.
Radiol Case Rep
; 19(6): 2286-2291, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38559653
12.
Baseline IgM Amounts Can Identify Patients with Poor Outcomes: Results from a Real-Life Single-Center Study on Classical Hodgkin Lymphoma.
Cancers (Basel)
; 16(4)2024 Feb 18.
Artigo
Inglês
| MEDLINE | ID: mdl-38398216
13.
Investigation of Serum Albumin as a Dynamic Treatment-Specific Surrogate for Outcomes in Patients With Myelofibrosis Treated With Ruxolitinib.
JCO Precis Oncol
; 8: e2300593, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38484210
14.
Targeted Metabolomics Highlights Dramatic Antioxidant Depletion, Increased Oxidative/Nitrosative Stress and Altered Purine and Pyrimidine Concentrations in Serum of Primary Myelofibrosis Patients.
Antioxidants (Basel)
; 13(4)2024 Apr 19.
Artigo
Inglês
| MEDLINE | ID: mdl-38671937
15.
A Journey Through JAK Inhibitors for the Treatment of Myeloproliferative Diseases.
Curr Hematol Malig Rep
; 18(5): 176-189, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37395943
16.
The pharmacotherapeutic management of patients with myelofibrosis: looking beyond JAK inhibitors.
Expert Opin Pharmacother
; 24(13): 1449-1461, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37341682
17.
Polycythemia Vera: Barriers to and Strategies for Optimal Management.
Blood Lymphat Cancer
; 13: 77-90, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-38146420
18.
AIPSS-MF machine learning prognostic score validation in a cohort of myelofibrosis patients treated with ruxolitinib.
Cancer Rep (Hoboken)
; 6(10): e1881, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37553891
19.
ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis.
Cancers (Basel)
; 16(1)2023 Dec 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38201581
20.
Handheld Ultrasound or Conventional Ultrasound Devices in Patients Undergoing HCT: A Validation Study.
J Clin Med
; 12(2)2023 Jan 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36675449